The Supreme Court is set to hear oral arguments on Tuesday, March 26, in a case that could have a significant impact on how mifepristone — the first drug used in a two-drug medication abortion regimen — is used and prescribed in the United States.surrounds the U.S.
“Women should have the ongoing care of a doctor when taking high risk drugs. But in recent years, the FDA has recklessly removed nearly every safeguard the agency previously considered necessary for abortion drugs, including in-person doctor visits to check for ectopic pregnancies, severe bleeding, and life-threatening infections,” Baptist added. “Without question, the FDA’s actions made taking high-risk abortion drugs less safe for women.”to take up the case in December of 2023.
Elrod wrote that at the preliminary stage, plaintiffs “have made a substantial showing” that the 2016 and 2021 rule changes violate the Administrative Procedure Act . The lawsuit details how, in 2016, the FDA extended the permissible gestational age for which a girl or woman may take the abortion drugs. Then, in 2021, the FDA allowed abortionists to send mifepristone through the mail, which the ADF says was “in direct violation of federal law.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: KPBSnews - 🏆 240. / 63 Read more »
Source: 6abc - 🏆 250. / 63 Read more »
Source: ABC7 - 🏆 67. / 68 Read more »
Source: NPR - 🏆 96. / 63 Read more »
Source: ABC7NY - 🏆 592. / 51 Read more »
Source: fox5ny - 🏆 587. / 51 Read more »